Insider · CIK 0002014639
Christian Heidbreder
Files at INDV (Indivior Pharmaceuticals, Inc.). First filing Jun 12, 2026, latest Jun 12, 2026.
Christian Heidbreder files SEC Form 4 as officer at INDV (Indivior Pharmaceuticals, Inc.). Since Jun 12, 2026, Christian Heidbreder has reported 0 open-market buys worth $0 and 1 open-market sell worth $707k, the latest filed on Jun 12, 2026.
A track record needs three past buys with six months of prices behind them; Christian Heidbreder has 0, so none is measured yet.
The newest scored trade: sold $707k of INDV on Jun 11, 2026, filed Jun 12, 2026, scored 24 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $707k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INDV: Indivior Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | Indivior Pharmaceuticals, Inc. | $707k 18,586 shares | -8% | +179% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 10, 2026 | INDV Indivior Pharmaceuticals, Inc. | 18,586 0.02% of outstanding | $765k | Jul 10, 2026 | $707k |
| Jun 11, 2026 | INDV Indivior Pharmaceuticals, Inc. | 18,586 0.02% of outstanding | $707k | Jun 11, 2026 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | INDV Indivior Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -18,586 | $38.06 | $707k | 227,923 | Jun 12, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Common Stock | +101,544 | - | - | 292,306 | Mar 5, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | FTax withholding Common Stock | -45,797 | $31.98 | $1.5M | 246,509 | Mar 5, 2026 |
| Mar 3, 2026 | INDV Indivior Pharmaceuticals, Inc. | MOption exercise Performance Stock Unitsderivative | -132,565 | - | - | 0 | Mar 5, 2026 |
| Feb 10, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +33,622 | $0.00 | $0 | 190,762 | Feb 12, 2026 |
| Feb 9, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Performance Stock Unitsderivative | +132,565 | $0.00 | $0 | 132,565 | Feb 12, 2026 |
Questions about Christian Heidbreder
Answered from the filings on this page, as of the latest one.
Is Christian Heidbreder buying or selling?
In the last 12 months Christian Heidbreder reported 0 open-market buys worth $0 and 1 open-market sell worth $707k on SEC Form 4; the latest was sold $707k of INDV on Jun 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Christian Heidbreder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christian Heidbreder has 0.
Where does Christian Heidbreder file Form 4?
Christian Heidbreder has filed Form 4 at INDV (Indivior Pharmaceuticals, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.